Association of high body lead store with severe intracranial carotid atherosclerosis

NeuroToxicology

Volumn 30, Issue 6, 2009, Pages 876-880

  Lee, Tsong Hai ^a   Tseng, Mei Chun ^b   Chen, Chi Jen ^c   Lin, Ja Liang ^d  

^a Stroke Section   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Angiography; Atherosclerosis; Carotid artery; Lead; Stroke

Indexed keywords

LEAD;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINALYSIS; VERTEBRAL ARTERY;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ASSOCIATION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LEAD; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY, ATOMIC; STROKE;

EID: 71349085779     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.07.004     Document Type: Article

References (48)

1. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., and Marsh III E.E. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
2. Adams Jr. H.P., Kappelle L.J., Biller J., Gordon D.L., Love B.B., Gomez F., and Heffner M. Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol 52 (1995) 491-495
3. Alter M. Black-white differences in stroke frequency: challenges for research. Neuroepidemiology 13 (1994) 301-307
4. Behringer D., Craswell P., Mohl C., Stoeppler M., and Ritz E. Urinary lead excretion in uremic patients. Nephron 42 (1986) 323-329
5. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-53.
6. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 99 (2006) 692-705
7. Bogousslavsky J., and Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 10 (1992) 113-124
8. Bradbury M.W., and Deane R. Brain endothelium and interstitium as sites for effects of lead. Ann NY Acad Sci 529 (1988) 1-8
9. Burke T.A., and Venketasubramanian R.N. The epidemiology of stroke in the East Asian region: a literature-based review. Int J Stroke 1 (2006) 208-215
10. Ekong E.B., Jaar B.G., and Weaver V.M. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int 70 (2006) 2074-2084
11. Emmerson B.T. Chronic lead nephropathy: the diagnostic use of calcium EDTA and the association with gout. Aust Ann Med 12 (1963) 310-324
12. Feldmann E., Daneault N., Kwan E., Ho K.J., Pessin M.S., Langenberg P., and Caplan L.R. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40 (1990) 1541-1545
13. From the NIH: 1980. New standards for classification and diagnosis of diabetes. JAMA 1980;243:2296-7.
14. Fujiwara Y., Kaji T., Sakurai S., Sakamoto M., and Kozuka H. Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells. Toxicology 117 (1997) 193-198
15. Fujiwara Y., Kaji T., Yamamoto C., Sakamoto M., and Kozuka H. Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells. Toxicology 98 (1995) 105-110
16. Glenn B.S., Stewart W.F., Links J.M., Todd A.C., and Schwartz B.S. The longitudinal association of lead with blood pressure. Epidemiology 14 (2003) 30-36
17. Goldstein L.B., Adams R., Alberts M.J., Appel L.J., Brass L.M., Bushnell C.D., Culebras A., DeGraba T.J., Gorelick P.B., Guyton J.R., Hart R.G., Howard G., Kelly-Hayes M., Nixon J.V., and Sacco R.L. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113 (2006) e873-e923
18. Hoffmann D., Hoffmann I., and El Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14 (2001) 767-790
19. Hu H., Aro A., Payton M., Korrick S., Sparrow D., Weiss S.T., and Rotnitzky A. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275 (1996) 1171-1176
20. Hu H., Shih R., Rothenberg S., and Schwartz B.S. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115 (2007) 455-462
21. Hu H.H., Sheng W.Y., Chu F.L., Lan C.F., and Chiang B.N. Incidence of stroke in Taiwan. Stroke 23 (1992) 1237-1241
22. Jeng J.S., and Su T.C. Epidemiological studies of cerebrovascular diseases and carotid atherosclerosis in Taiwan. Acta Neurol Taiwan 16 (2007) 190-202
23. Kaji T. Cell biology of heavy metal toxicity in vascular tissue. Yakugaku Zasshi 124 (2004) 113-120
24. Kristensen B., Malm J., Carlberg B., Stegmayr B., Backman C., Fagerlund M., and Olsson T. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 28 (1997) 1702-1709
25. Kromhout D. Blood lead and coronary heart disease risk among elderly men in Zutphen, The Netherlands. Environ Health Perspect 78 (1988) 43-46
26. Kuliczkowski W., Jolda-Mydlowska B., Kobusiak-Prokopowicz M., ntonowicz-Juchniewicz J., and Kosmala W. Effect of heavy metal ions on function of vascular endothelium in patients with ischemic heart disease. Pol Arch Med Wewn 111 (2004) 679-685
27. Leung S.Y., Ng T.H., Yuen S.T., Lauder I.J., and Ho F.C. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 24 (1993) 779-786
28. Lin J.L., Lin-Tan D.T., Hsu K.H., and Yu C.C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348 (2003) 277-286
29. Linnamagi U., and Kaasik A.E. Changes of local cerebral blood flow concomitant to lead-exposure in adult rabbits. Acta Neurol Scand 92 (1995) 491-496
30. Liu H.M., Tu Y.K., Yip P.K., and Su C.T. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke 27 (1996) 650-653
31. Lu K.P., Zhao S.H., and Wang D.S. The stimulatory effect of heavy metal cations on proliferation of aortic smooth muscle cells. Sci China B 33 (1990) 303-310
32. Menke A., Muntner P., Batuman V., Silbergeld E.K., and Guallar E. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 114 (2006) 1388-1394
33. Michaels D., Zoloth S.R., and Stern F.B. Does low-level lead exposure increase risk of death? A mortality study of newspaper printers. Int J Epidemiol 20 (1991) 978-983
34. Moller L., and Kristensen T.S. Blood lead as a cardiovascular risk factor. Am J Epidemiol 136 (1992) 1091-1100
35. Muntner P., Menke A., DeSalvo K.B., Rabito F.A., and Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165 (2005) 2155-2161
36. Mykkanen H., Rasanen L., Ahola M., and Kimppa S. Dietary intakes of mercury, lead, cadmium and arsenic by Finnish children. Hum Nutr Appl Nutr 40 (1986) 32-39
37. Navas-Acien A., Selvin E., Sharrett A.R., Calderon-Aranda E., Silbergeld E., and Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109 (2004) 3196-3201
38. Neuberger J.S., Hu S.C., Drake K.D., and Jim R. Potential health impacts of heavy-metal exposure at the Tar Creek Superfund site, Ottawa County, Oklahoma. Environ Geochem Health 31 (2009) 47-59
39. Pocock S.J., Shaper A.G., Ashby D., Delves H.T., and Clayton B.E. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect 78 (1988) 23-30
40. Qureshi A.I., Safdar K., Patel M., Janssen R.S., and Frankel M.R. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke 26 (1995) 1995-1998
41. Revis N.W., Zinsmeister A.R., and Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci USA 78 (1981) 6494-6498
42. Schober S.E., Mirel L.B., Graubard B.I., Brody D.J., and Flegal K.M. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 114 (2006) 1538-1541
43. Staessen J.A., Buchet J.P., Ginucchio G., Lauwerys R.R., Lijnen P., Roels H., and Fagard R. Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. Working Groups. J Cardiovasc Risk 3 (1996) 26-41
44. Steenland K., Selevan S., and Landrigan P. The mortality of lead smelter workers: an update. Am J Public Health 82 (1992) 1641-1644
45. Vaziri N.D., Ding Y., and Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 298 (2001) 679-685
46. Voors A.W., Shuman M.S., and Johnson W.D. Additive statistical effects of cadmium and lead on heart-related disease in a North Carolina autopsy series. Arch Environ Health 37 (1982) 98-102
47. Weinhold B. Environmental cardiology: getting to the heart of the matter. Environ Health Perspect 112 (2004) A880-A887
48. Williams L.S., Garg B.P., Cohen M., Fleck J.D., and Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 49 (1997) 1541-1545